Turn science into treatments. With Moderna. In Montréal.
Moderna’s mission is to realize the full potential of messenger RNA (mRNA) science to develop a new generation of innovative therapies designed to improve patients’ lives for years to come.
At a glance
- Global headquarters: Cambridge, Massachusetts, United States
- Sector: Life sciences and health technologies
- In Greater Montréal: First employees hired in 2021, construction of the manufacturing facility started in 2022, and the first locally produced vaccines were delivered in 2025
- Known for: Its COVID-19 vaccine
- Expertise: Local production of mRNA vaccines
From health sovereignty to a stronger biomedical ecosystem
A pioneer in messenger RNA vaccines, Moderna has built its success on a flexible and rapid technology platform that is paving the way for a new generation of treatments targeting infectious diseases, cancer, and rare diseases.
Known worldwide for its COVID-19 vaccine, the company reached a major milestone with the establishment of its biomanufacturing facility in Laval in 2024. The site provides Canada with local vaccine production capacity, helping meet routine healthcare needs while ensuring readiness for future public health emergencies.
By choosing Greater Montréal, Moderna has positioned itself at the heart of a globally recognized ecosystem renowned for its expertise in biopharmaceuticals, clinical research, and life sciences innovation.
A strategic asset for Moderna and for the local economy
Moderna’s presence is generating lasting and strategic benefits for Québec and Canada:
- Strengthens health sovereignty through locally anchored biomedical development and manufacturing capabilities.
- Reinforces Greater Montréal’s position as a global hub for messenger RNA innovation and life sciences.
- Supports the growth of the local ecosystem by advancing cutting-edge research, biopharmaceutical manufacturing, and technology transfer.
- Accelerates collaboration among industry, universities, and research centres, fostering the development of next-generation medical solutions.
Join Greater Montréal’s life sciences ecosystem
Greater Montréal has emerged as one of North America’s leading hubs where life sciences, biopharmaceutical innovation, and artificial intelligence converge. It offers a unique environment to innovate, collaborate, and accelerate the development of next-generation healthcare solutions.
Learn more about Greater Montréal’s competitive advantages and investment opportunities in life sciences and health technologies.
“Our success in Québec inspires other companies to establish operations here. It’s a win-win situation: We thrive through our partnerships with universities and governments, and our presence helps strengthen the attractiveness of the ecosystem for everyone.”
Stefan Raos
General Manager
Moderna Canada
Learn more
Close